Medicare Enrolled

Dr. Brian Steingo, MD

Neurology · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
9970 CENTRAL PARK BLVD N STE 207, Boca Raton, FL 33428
5614821027
In practice since 2006 (19 years)
NPI: 1417907163 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Steingo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steingo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Steingo

Dr. Brian Steingo is a neurology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Steingo performed 321 Medicare services across 244 unique beneficiaries.

Between the years covered by Open Payments, Dr. Steingo received a total of $1,057,534 from 59 pharmaceutical and/or device companies across 2116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Steingo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 321 Medicare services$ $1,057,534 industry payments

Medicare Practice Summary

Medicare Utilization ↗
321
Medicare services
Bottom 37% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
244
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)214$83$402
Office visit, established patient, complex (40-54 min)96$143$788
Blood draw (venipuncture)11$8$10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,057,534
Total received (2018-2024)
Avg $151,076/year across 7 years
Top 1% in FL for neurology
59
Companies
2,116
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$973,516 (92.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$75,123 (7.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,894 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$63,999
2023
$71,140
2022
$130,575
2021
$125,374
2020
$95,391
2019
$241,374
2018
$329,680

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$364,458
Biogen, Inc.
$262,677
EMD Serono, Inc.
$131,171
Genentech USA, Inc.
$97,294
Alexion Pharmaceuticals, Inc.
$78,252
Novartis Pharmaceuticals Corporation
$25,115
Celgene Corporation
$22,018
Teva Pharmaceuticals USA, Inc.
$21,156
E.R. Squibb & Sons, L.L.C.
$15,583
Janssen Pharmaceuticals, Inc
$14,465
Genentech, Inc.
$8,950
Acorda Therapeutics, Inc
$6,115
Mallinckrodt LLC
$4,685
TG Therapeutics, Inc.
$1,074
ANI Pharmaceuticals, Inc.
$611
Amgen Inc.
$410
Mallinckrodt Enterprises LLC
$318
ABBVIE INC.
$297
UCB, Inc.
$265
SCILEX PHARMACEUTICALS INC.
$201
AbbVie Inc.
$200
Octapharma USA, Inc.
$186
Allergan Inc.
$173
ARGENX US, INC.
$131
Mallinckrodt Hospital Products Inc.
$129
Vertical Pharmaceuticals, LLC
$127
Boston Scientific Corporation
$107
Neurocrine Biosciences, Inc.
$93
Grifols USA, LLC
$92
Sunovion Pharmaceuticals Inc.
$90
Merz Pharmaceuticals, LLC
$77
Eisai Inc.
$75
SANOFI-AVENTIS U.S. LLC
$73
Lilly USA, LLC
$71
Horizon Therapeutics plc
$61
CSL Behring
$57
Neurelis, Inc.
$55
BANNER LIFE SCIENCES, LLC
$54
Bayer HealthCare Pharmaceuticals Inc.
$52
Allergan, Inc.
$44
Mitsubishi Tanabe Pharma America, Inc.
$40
MDD US Operations, LLC
$40
Scilex Pharmaceuticals Inc.
$37
SK Life Science, Inc.
$36
InSightec,Inc
$33
LivaNova USA, Inc.
$32
PFIZER INC.
$28
Amneal Pharmaceuticals LLC
$26
AstraZeneca Pharmaceuticals LP
$25
MITSUBISHI TANABE PHARMA AMERICA, INC.
$25
Alnylam Pharmaceuticals Inc.
$24
Abbott Laboratories
$22
Aprecia Pharmaceuticals, LLC
$22
Supernus Pharmaceuticals, Inc.
$20
AQUESTIVE THERAPEUTICS, INC.
$17
Kyowa Kirin, Inc.
$16
ACADIA Pharmaceuticals Inc
$14
Vanda Pharmaceuticals Inc.
$13
Corium, LLC
$3
Top 3 companies account for 71.7% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · DISEASE STATE · Enspryng · Evrysdi · Exablate · Fabhalta · Fycompa · GILENYA · Gamunex-C · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LUX-Dx Insertable Cardiac Monitor · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NAMZARIC · NO PRODUCT DISCUSSED · NUPLAZID · Nayzilam · Nourianz · OCREVUS · ONPATTRO · OSMOLEX ER · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SYMPAZAN · Soliris · Spritam · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYVGART · VYVGART HYTRULO · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.

Equivalent to $329,450 per 100 Medicare services performed
Looking for a neurology in Boca Raton?
Compare neurologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
165
Per 100K population
10.9
County median income
$81,115
Nearest hospital
WEST BOCA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Steingo is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Steingo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Steingo performed 214 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Steingo receive payments from pharmaceutical companies?
Yes. Dr. Steingo received a total of $1,057,534 from 59 companies across 2,116 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steingo's costs compare to other neurologys in Boca Raton?
Dr. Steingo's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steingo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →